Forest Laboratories, Inc. to Host Investor Meeting to Review Company’s Late-Stage Product Development Pipeline and Commercialization Strategy

NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX), an international manufacturer and marketer of pharmaceutical products, today announced that it will host a meeting on Wednesday, June 20, 2012 to review its late-stage product development pipeline and commercialization strategy. The meeting will feature therapeutic area presentations by senior leadership from the Forest Research Institute, Inc., the Company’s research and development arm, and product commercialization strategy by senior corporate executives, with emphasis placed on the Company’s late-stage product opportunities and new product launches.

MORE ON THIS TOPIC